Arvo Haenni

1.1k total citations
38 papers, 807 citations indexed

About

Arvo Haenni is a scholar working on Surgery, Nutrition and Dietetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Arvo Haenni has authored 38 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 14 papers in Nutrition and Dietetics and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Arvo Haenni's work include Magnesium in Health and Disease (14 papers), Bariatric Surgery and Outcomes (12 papers) and Parathyroid Disorders and Treatments (7 papers). Arvo Haenni is often cited by papers focused on Magnesium in Health and Disease (14 papers), Bariatric Surgery and Outcomes (12 papers) and Parathyroid Disorders and Treatments (7 papers). Arvo Haenni collaborates with scholars based in Sweden, Netherlands and Qatar. Arvo Haenni's co-authors include Hans Lithell, Magnus Sundbom, Håkan Åhlström, Joel Kullberg, Hans-Erik Johansson, Lars Lind, F. Anders Karlsson, David Edholm, Richard Reneland and Björn Zethelius and has published in prestigious journals such as American Journal of Clinical Nutrition, Nutrients and Metabolism.

In The Last Decade

Arvo Haenni

38 papers receiving 773 citations

Peers

Arvo Haenni
Marco Versiero Italy
K. G. Stanton Australia
Sameer Stas United States
Yuji Hirai Japan
Alessandro Cavarape Italy
Srividya Kidambi United States
P N Hopkins United States
Petra Schling Germany
C. N. Ennis United Kingdom
P. Pizzocri Italy
Marco Versiero Italy
Arvo Haenni
Citations per year, relative to Arvo Haenni Arvo Haenni (= 1×) peers Marco Versiero

Countries citing papers authored by Arvo Haenni

Since Specialization
Citations

This map shows the geographic impact of Arvo Haenni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvo Haenni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvo Haenni more than expected).

Fields of papers citing papers by Arvo Haenni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvo Haenni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvo Haenni. The network helps show where Arvo Haenni may publish in the future.

Co-authorship network of co-authors of Arvo Haenni

This figure shows the co-authorship network connecting the top 25 collaborators of Arvo Haenni. A scholar is included among the top collaborators of Arvo Haenni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvo Haenni. Arvo Haenni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sundbom, Magnus, et al.. (2023). Glycemic variability and hypoglycemia before and after Roux-en-Y Gastric Bypass and Sleeve Gastrectomy – A cohort study of females without diabetes. Surgery for Obesity and Related Diseases. 20(1). 10–16. 3 indexed citations
2.
Sundbom, Magnus, et al.. (2019). Comparison of Meal Pattern and Postprandial Glucose Response in Duodenal Switch and Gastric Bypass Patients. Obesity Surgery. 29(7). 2210–2216. 7 indexed citations
3.
Haenni, Arvo, et al.. (2016). Methylphenidate toxicity after Roux-en-Y gastric bypass. Surgery for Obesity and Related Diseases. 12(5). e55–e57. 13 indexed citations
4.
Edholm, David, Joel Kullberg, F. Anders Karlsson, et al.. (2014). Changes in liver volume and body composition during 4 weeks of low calorie diet before laparoscopic gastric bypass. Surgery for Obesity and Related Diseases. 11(3). 602–606. 43 indexed citations
5.
Hedberg, Jakob & Arvo Haenni. (2012). Increased Plasma Magnesium Concentrations 3 Years After Biliopancreatic Diversion with Duodenal Switch. Obesity Surgery. 22(11). 1708–1713. 3 indexed citations
6.
7.
Bodén, Robert, Arvo Haenni, Leif Lindström, & Johan Sundström. (2009). Biochemical risk factors for development of obesity in first-episode schizophrenia. Schizophrenia Research. 115(2-3). 141–145. 12 indexed citations
8.
Johansson, Hans-Erik, Björn Zethelius, Màrgàretà Öhrvall, Magnus Sundbom, & Arvo Haenni. (2008). Serum Magnesium Status After Gastric Bypass Surgery in Obesity. Obesity Surgery. 19(9). 1250–1255. 21 indexed citations
9.
Öhrvall, Màrgàretà, Arvo Haenni, Magnus Sundbom, et al.. (2007). Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretion. Diabetic Medicine. 24(11). 1213–1220. 9 indexed citations
10.
Haenni, Arvo, et al.. (2002). Magnesium infusion improves endothelium-dependent vasodilation in the human forearm. American Journal of Hypertension. 15(1). 10–15. 21 indexed citations
11.
Haenni, Arvo, et al.. (2001). Serum magnesium status during lipid-lowering drug treatment in non[ndash ]insulin-dependent diabetic patients. Metabolism. 50(10). 1147–1151. 6 indexed citations
12.
Haenni, Arvo. (2001). Systolic blood pressure alterations during hyperinsulinemia are related to changes in ionized calcium status. American Journal of Hypertension. 14(11). 1106–1111. 4 indexed citations
13.
Haenni, Arvo, Richard Reneland, Lars Lind, & Hans Lithell. (2001). Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension. Journal of Hypertension. 19(1). 107–112. 20 indexed citations
14.
Reneland, Richard, et al.. (2000). Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril. Journal of Human Hypertension. 14(3). 175–180. 50 indexed citations
15.
Lind, Lars, et al.. (1998). Insulin resistance in essential hypertension is related to plasma renin activity. Journal of Human Hypertension. 12(6). 379–382. 17 indexed citations
16.
17.
Haenni, Arvo & Hans Lithell. (1996). Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension. Metabolism. 45(10). 1221–1229. 22 indexed citations
18.
Haenni, Arvo, Per‐Erik Andersson, Lars Lind, Christian Berne, & Hans Lithell. (1994). Electrolyte Changes and Metabolic Effects of Lisinopril/Bendrofluazide Treatment Results From a Randomized, Double-Blind Study With Parallel Groups. American Journal of Hypertension. 7(7_Pt_1). 615–622. 32 indexed citations
19.
20.
Haenni, Arvo & Hans Lithell. (1994). Treatment with a β-blocker with β2-agonism improves glucose and lipid metabolism in essential hypertension. Metabolism. 43(4). 455–461. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Versiero Breakdown of academic impact, for papers by K. G. Stanton Breakdown of academic impact, for papers by Sameer Stas Breakdown of academic impact, for papers by Yuji Hirai Breakdown of academic impact, for papers by Alessandro Cavarape Breakdown of academic impact, for papers by Srividya Kidambi Breakdown of academic impact, for papers by P N Hopkins Breakdown of academic impact, for papers by Petra Schling Breakdown of academic impact, for papers by C. N. Ennis Breakdown of academic impact, for papers by P. Pizzocri
Rankless by CCL
2026